MedPath
FDA Approval

Irinotecan Hydrochloride

March 10, 2021

HUMAN PRESCRIPTION DRUG LABEL

Irinotecan(20 mg in 1 mL)

Manufacturing Establishments (1)

Qilu Pharmaceutical (Hainan) Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

529131725

Products (3)

Irinotecan Hydrochloride

67184-0512

ANDA203380

ANDA (C73584)

INTRAVENOUS

April 15, 2020

WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACT
Code: 042LAQ1IISClass: ACTIBQuantity: 20 mg in 1 mL

Irinotecan Hydrochloride

67184-0513

ANDA203380

ANDA (C73584)

INTRAVENOUS

April 15, 2020

LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 042LAQ1IISClass: ACTIBQuantity: 20 mg in 1 mL
SORBITOLInactive
Code: 506T60A25RClass: IACT

Irinotecan Hydrochloride

67184-0511

ANDA203380

ANDA (C73584)

INTRAVENOUS

April 15, 2020

SORBITOLInactive
Code: 506T60A25RClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 042LAQ1IISClass: ACTIBQuantity: 20 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath